Related Experiment Video
Updated: Feb 24, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular
Yasmin M Shaalan1, H Handoussa1, R A Youness1
1a Faculty of Pharmacy and Biotechnology, Pharmaceutical Biology Department , German University in Cairo , Cairo , Egypt.
Abstract:
Insulin-like growth factor-2 binding proteins (IGF2BPs) are oncogenic RNA-binding proteins, highly up-regulated in HCC, and were recently validated as direct targets of the tumour suppressor miR-1275. It is worth noting that around 47% of FDA approved anticancer drugs are derived from plants. Modulation by miRNAs and their cellular signalling cascades could constitute new pathways by which these phytochemicals exert their effects. This study aimed to investigate the potential use of Tamarix articulata, quercetin and epigallocatechin gallate (EGCG) in HCC and how these phytochemicals could epigenetically modulate the IGF axis using their impact on miR-1275. T. articulata ethyl acetate fraction significantly reduced the viability of Huh-7 cells compared to control cells. Treatment with T. articulata ethyl acetate fraction, quercetin and EGCG significantly enhanced miR-1275, while suppressed IGF2BP1 and IGF2BP3 mRNA expression levels. In summary, T. articulata, quercetin and EGCG have important implications for HCC molecular-targeted therapy through destabilizing the interplay between miR-1275 and the IGF axis.
Insights
Tamarix articulata, quercetin, and epigallocatechin gallate (EGCG) show promise for hepatocellular carcinoma (HCC) therapy. These phytochemicals enhance miR-1275 and suppress oncogenic IGF2BPs, targeting the miR-1275/IGF axis.
Area of Science:
- Molecular Oncology
- Phytochemistry
- Epigenetics
Background:
- Insulin-like growth factor-2 binding proteins (IGF2BPs) are oncogenic, upregulated in hepatocellular carcinoma (HCC), and targeted by miR-1275.
- Plant-derived compounds are a significant source of anticancer drugs, potentially acting via miRNA modulation.
Purpose of the Study:
- To investigate the potential of Tamarix articulata, quercetin, and epigallocatechin gallate (EGCG) in HCC treatment.
- To explore how these phytochemicals epigenetically modulate the Insulin-like Growth Factor (IGF) axis through miR-1275.
Main Methods:
- Treatment of Huh-7 HCC cells with Tamarix articulata ethyl acetate fraction, quercetin, and EGCG.
- Assessment of cell viability.
- Quantification of miR-1275, IGF2BP1, and IGF2BP3 mRNA expression levels.
Main Results:
- Tamarix articulata ethyl acetate fraction significantly reduced Huh-7 cell viability.
- All tested phytochemicals significantly enhanced miR-1275 expression.
- Phytochemical treatments suppressed IGF2BP1 and IGF2BP3 mRNA levels.
Conclusions:
- Tamarix articulata, quercetin, and EGCG demonstrate potential for molecular-targeted HCC therapy.
- These phytochemicals disrupt the interaction between miR-1275 and the IGF axis, offering a novel therapeutic strategy.
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation

